Improve treatment and diagnostic decisions with fast, accurate, and non-invasive assessments of cardiorespiratory status using the MediPines AGM100®.
Results in under two minutes
O2 and CO2 gas levels from the lungs sampled at rest
Non-Invasive: resting breath sampling with no needles
The AGM100 measures oxygenation, ventilation, and pulmonary gas exchange, all with one simple test. Vitally important clinical information now available at the point-of-care.
Assessing respiratory impairment in patients is a critical aspect of clinical management. Traditionally, the Riley method (A-a gradient) has been the gold standard measure for gas exchange efficiency, but this approach...
Clinicians know that unlike other tests, the AGM100 provides accurate measurements of gas exchange impairment to differentiate healthy and sick patients...
Patients in respiratory distress require immediate medical attention. The ability to quickly identify hypoxemia is crucial...
Clinicians using the AGM100 can compress the time to diagnosis and treatment decision throughout a patient's care continuum.
Broad Applicability from hospitals to clinics
“Innovative technologies are accelerating access to healthcare everywhere, we must ensure that they (innovative technologies) are readily available in all health facilities, fairly priced and quality-assured...”
“The AGM100 is already playing a crucial role in respiratory assessment and treatment in a quickly growing number of hospitals across the nation."
“These winners represent some of the most promising emerging medical device innovations in the diagnosis, treatment, and care of children affected..."